0 items USD 0.00Search
Your search for "Internet of Things (IoT)" gave back 179 results.
Non-alcoholic steatohepataitis (NASH) Pipeline Analysis鈥� gives comprehensive insights on the various drugs being developed for the treatment of NASH...
颁补迟补濒辞驳:听
IQ4I
February 2017
Price: USD 3,600.00
Cells are the biological units that are used for the identification and mapping of the basic biochemical and physical processes of life. Analysis of...
颁补迟补濒辞驳:听
IQ4I
January 2017
Price: USD 4,950.00
The present Competitive Intelligence Report about alpha1-proteinase inhibitors (alpha1-PI), alpha1-antitrypsin (AAT) and elastase inhibitors provides...
颁补迟补濒辞驳:听
La Merie Publishing
July 2014
Price: USD 272.00
This pdf report contains information about Antibody-Drug Conjugates (ADCs) released during the month of October 2016. Featured presentations of...
颁补迟补濒辞驳:听
La Merie Publishing
November 2016
Price: USD 225.00
This pdf report contains information about Bispecific Antibodies released during the month of October 2016. Featured presentations of October 2016...
颁补迟补濒辞驳:听
La Merie Publishing
November 2016
Price: USD 225.00
This pdf report contains information about TCR & CAR engineered T-cells and NK cells released during the month of October 2016. Featured...
颁补迟补濒辞驳:听
La Merie Publishing
November 2016
Price: USD 225.00
The present Competitive Intelligence report about Cancer Vaccines provides a competitor evaluation in the field of novel prophylactic and therapeutic...
颁补迟补濒辞驳:听
La Merie Publishing
March 2014
Price: USD 1,112.00
The report 鈥淎ntibody Technologies and Attrition Rates 鈥� an industry analysis 2013鈥� is based on the identification of the antibody generation...
颁补迟补濒辞驳:听
La Merie Publishing
March 2013
Price: USD 2,960.00
VEGF Antibodies 鈥� Bevacizumab and Ranibizumab Biosimilars and Biosuperiors The present Competitive Intelligence Report about VEGF Antibodies 鈥�...
颁补迟补濒辞驳:听
La Merie Publishing
February 2014
Price: USD 401.00
CD20 Antibodies - Rituximab Biosimilars and Biobetters/Biosuperiors The present Competitive Intelligence Report about CD20 Antibodies - Rituximab...
颁补迟补濒辞驳:听
La Merie Publishing
February 2014
Price: USD 401.00
Novel Prophylactic and Therapeutic Approaches to Manage and Prevent Clostridium difficile Infections (CDI) Clostridium difficile infections (CDI) are...
颁补迟补濒辞驳:听
La Merie Publishing
January 2014
Price: USD 267.00
Pharmaceutical excipients are inactive substances in the drug which helps in modulating solubility, bioavailability and stability of active...
颁补迟补濒辞驳:听
IQ4I
September 2016
Price: USD 4,500.00
Competitor Analysis: Bispecific Antibodies for Cancer, Inflammatory & Other Diseases This Competitive Intelligence report about Bispecific...
颁补迟补濒辞驳:听
La Merie Publishing
June 2016
Price: USD 560.00
鈥淧ancreatic Beta-cell Protection Hot Targets & Pipeline Analysis鈥� gives comprehensive insight on the various drugs being developed for the...
颁补迟补濒辞驳:听
IQ4I
August 2016
Price: USD 3,600.00
Stem Cell Therapies - Global Trends in the Competitive, Technological and R&D Landscape Summary GBI Research鈥檚 latest report, "Stem Cell...
CBR Pharma Insights
July 2016
Price: USD 2,995.00
听
